Major clinical breast cancer study begins

Apr 04, 2007

U.S. medical researchers have found combining two drugs targeted against HER2-positive breast cancer might offer more benefit than just using one.

Dr. Edith Perez, director of the Mayo Clinic's Jacksonville, Fla., Breast Clinic., is leading a national trial with 109 participants that will look at the safety and benefit of adding lapatinib (Tykerb) to trastuzumab (Herceptin) for the treatment of early stage HER2-positive breast cancer.

The study -- the first major clinical research of its kind -- started March 16 with patient recruitment.

"Worldwide, no more than 100 patients have been tested with this combination treatment, so we are pleased that we now offer a comprehensive study in the United States to assess the possible benefit of this therapy," said Perez.

She will lead a consortium of 35 investigators who will enroll 109 participants at up to 100 different cancer treatment centers across the nation.

"We are finding that the best way to treat a cancer is to understand the biological characteristics of the cancer and then use therapies directed at those specific biological or molecular abnormalities," she added.

Information about the study is available at
clinicaltrials.mayo.edu.

Copyright 2007 by United Press International

Explore further: AstraZeneca cancer drug, companion test approved

add to favorites email to friend print save as pdf

Related Stories

World's oldest penguin undergoes cancer radiation

Dec 12, 2014

A toddler on Tuesday peered through thick glass as Tess – the world's oldest African penguin, representing an endangered species set to vanish in the child's lifetime – dove into her pool at the Pueblo Zoo. It was the ...

Recommended for you

Putting the brakes on cancer

Dec 19, 2014

A study led by the University of Dundee, in collaboration with researchers at our University, has uncovered an important role played by a tumour suppressor gene, helping scientists to better understand how ...

Peanut component linked to cancer spread

Dec 19, 2014

Scientists at the University of Liverpool have found that a component of peanuts could encourage the spread and survival of cancer cells in the body.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.